Fibrosis and heart failure
@article{Segura2012FibrosisAH, title={Fibrosis and heart failure}, author={Ana Maria Segura and O. Howard Frazier and L. Maximilian Buja}, journal={Heart Failure Reviews}, year={2012}, volume={19}, pages={173-185} }
The extracellular matrix (ECM) is a living network of proteins that maintains the structural integrity of the myocardium and allows the transmission of electrical and mechanical forces between the myocytes for systole and diastole. During ventricular remodeling, as a result of iterations in the hemodynamic workload, collagen, the main component of the ECM, increases and occupies the areas between the myocytes and the vessels. The resultant fibrosis (reparative fibrosis) is initially a…
267 Citations
Mechanisms of Cardiac Fibrosis and Heart Failure
- Biology, Medicine
- 2015
The structure and function of the cardiac ECM from development to various pathological states is reviewed as well as new findings in the study of reverse cardiac remodelling following unloading of the left ventricle are highlighted.
Remodelling of the Cardiac Extracellular Matrix: Role of Collagen Degradation and Accumulation in Pathogenesis of Heart Failure
- Biology
- 2015
An overview of the mechanisms involved in myocardial fibrosis, the disease-dependent nature and consequence of different types of Fibrosis, clinical biomarkers of collagen turnover, and potential therapeutic approaches in managing the myocardium are provided.
The fibrosis-cell death axis in heart failure
- Medicine, BiologyHeart Failure Reviews
- 2016
The interaction between cardiac fibrosis, cardiomyocyte hypertrophy and cell death, and potential strategies for tackling progressive cardiac remodeling and HF are described.
Mechanisms of cardiac collagen deposition in experimental models and human disease.
- Medicine, BiologyTranslational research : the journal of laboratory and clinical medicine
- 2019
The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart
- Biology, EngineeringJournal of clinical medicine
- 2017
The current status of knowledge of mechanotransduction signaling pathways in cardiac fibroblasts that culminate in pro-fibrotic gene expression are reviewed.
Remodeling and Fibrosis of the Cardiac Muscle in the Course of Obesity—Pathogenesis and Involvement of the Extracellular Matrix
- Medicine, BiologyInternational journal of molecular sciences
- 2022
Excessive collagen deposition in the extracellular matrix (ECM) in the course of obesity may increase the stiffness of the myocardium and thereby deteriorate the heart diastolic function and facilitate the occurrence of HFpEF.
Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.
- BiologyAmerican journal of physiology. Heart and circulatory physiology
- 2018
In conclusion, this study demonstrated key cardioprotective effects of LOX inhibition against adverse cardiac remodeling due to chronic VO and improved ventricular collagen and matrix metalloproteinase/tissue inhibitor of metalliproteinase profiles.
The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking.
- Biology, MedicineBiochimica et biophysica acta. Molecular cell research
- 2019
Reprint of "The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking".
- Biology, MedicineBiochimica et biophysica acta. Molecular cell research
- 2019
Cardiomyocyte damage control in heart failure and the role of the sarcolemma
- BiologyJournal of Muscle Research and Cell Motility
- 2019
A novel perspective on sar colemma remodelling is presented by considering whether targeting proteins that regulate sarcolemma injury-repair may hold promise for developing new strategies to attenuate HF progression.
References
SHOWING 1-10 OF 164 REFERENCES
Cellular and molecular pathways to myocardial necrosis and replacement fibrosis
- BiologyHeart Failure Reviews
- 2010
It is now further recognized that Ca2+ overloading of cardiac myocytes and mitochondria serves as a prooxidant and which is counterbalanced by an intrinsically coupled Zn2+ entry serving as antioxidant, and the prospect of raising antioxidant defenses by increasing intracellular Zn 2+ with adjuvant nutriceuticals can be preferentially exploited to uncouple this intrinsically coupled Ca2–Zn2- dyshomeostasis.
Cardiac interstitium in health and disease: the fibrillar collagen network.
- Biology, MedicineJournal of the American College of Cardiology
- 1989
A look between the cardiomyocytes: the extracellular matrix in heart failure.
- Biology, MedicineMayo Clinic proceedings
- 2006
The extracellular matrix of the heart dynamically interacts with various cellular components of the myocardium, including the myocytes and connective tissue cells, to provide a focus to its often overlooked contribution to the development and progression of heart failure and thereby its potential role as a target for therapy for heart failure.
Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support.
- Medicine, BiologyThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
- 2001
Cardiac remodeling and failure From molecules to man (Part II).
- BiologyCardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
- 2005
Mechanisms of Disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease
- Medicine, BiologyNature Clinical Practice Cardiovascular Medicine
- 2005
The clinical relevance of ventricular fibrosis is that it might contribute to the increased cardiac risk of patients with hypertensive heart disease and the therapeutic strategies aimed to promote its reduction are discussed.
Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
- Biology, MedicineCardiovascular research
- 2000
Targeting pathological remodeling: concepts of cardioprotection and reparation.
- Biology, MedicineCirculation
- 2000
Together with thehypertrophy of left ventricular myocytes, these iterations in tissue structure in HHD create a pathological hypertrophy that predisposes to an enhanced risk of adverse cardiovascular events, including myocardial infarction, diastolic and/or systolic ventricular dysfunction, symptomatic heart failure, and arrhythmias.
Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System
- Biology, MedicineCirculation
- 1991
It can be concluded that arterial hypertension together with elevated circulating aldosterone are associated with cardiac fibroblast involvement and the resultant heterogeneity in tissue structure and the stage is set to prevent pathological LVH resulting from myocardial fibrosis as well as to reverse it.
Extracellular matrix and cardiovascular diseases.
- Medicine, BiologyThe Canadian journal of cardiology
- 1996
The accumulation of ECM in the cardiovascular system plays an important role in the development of heart failure after myocardial infarction and hypertension, as well as in vascular hypertrophy and restenosis.